Julia Lewis Archives
Study tracks new end-stage renal disease therapy
Aug. 7, 2014—Researchers in Vanderbilt’s Division of Nephrology conducted a Phase 3 clinical trial to test the safety and efficacy of a new drug to treat patients with end-stage renal disease.